Lonza Clonetics KGM-Gold adult and neonatal keratinocytes

Tuesday, 22 March, 2011 | Supplied by: Capsugel Australia Pty Ltd
Lonza Clonetics KGM-Gold adult and neonatal keratinocytes

The Clonetics KGM-Gold NHEK normal human epidermal keratinocytes have longer guaranteed life spans than Lonza’s original KGM or KGM-2 cells.

Achieve ≥18 total population doublings for adult cells and ≥20 population doublings for neonatal cells when using the growth medium.

All cells are performance tested in the growth medium and test negative for mycoplasma, bacteria, yeast and fungi. HIV-1, hepatitis B/C are not detected for all donors and/or cell lots.

A certificate of analysis is provided for each cell lot purchased. Clonetics cells are guaranteed to perform as indicated when used with Clonetics media and reagents.

Online: lonzabioscience.com.au
Phone: 1300 657508
Related Products

Navinci Diagnostics Naveni CD8/MHC-I Atto647N proximity ligation assay (PLA) kit

The Naveni CD8/MHC-I Atto647N is an in situ proximity ligation assay kit for the detection of the...

Invent Biotechnologies Minute Single Cell Nuclei Kits

The Invent Biotechnologies Minute Single Cell Nuclei Kits use proprietary spin column-based...

MP Biomedicals MagBeads FastDNA MaxPure Kit for Feces and Fecal Preservation Solution

MP Biomedicals MagBeads FastDNA MaxPure Kit for Feces is a magnetic bead-based solution...

Content from other channels on our network

From bottleneck to backbone: rethinking water in F&B manufacturing

Barry Callebaut appoints new Chief Operating Officer

Arnott's Group celebrates its suppliers at Sydney event

Record growth for food and grocery manufacturing sector, AFGC reports

eBeam technology evaluated for poultry food safety and flavour

Engineers Australia supports national engineer registration

Asahi to use recycled material for all plastic soft drink bottles

Queensland Government and CSIRO launch free R&D program for SMEs

Applications open in WA for submarine sustainment contracts

Construction begins on WA gallium project

Sale of Hobart Private Hospital to Calvary raises concerns

Opinion: The growing risk of AI-driven self-diagnosis in breast health

A new national approach to clinical governance

Opinion: The debate over the government's aged care algorithm is missing the point

Commonwealth Home Support Program extended to 30 June 2029

  • All content Copyright © 2026 Westwick-Farrow Pty Ltd